In response to requests, FDA has added 30 days to the public comment period for its June 4 proposal to release masked and/or de-identified nonsummary safety and efficacy data from marketing applications. (See Also see "FDA Wants To Release “Masked” Marketing Application Data To Researchers" - Medtech Insight, 10 June, 2013..) The new deadline for submitting comments on the proposal is Oct. 31.
FDA is seeking comments on the concept of making masked and/or de-identified pre-clinical and clinical data from marketing applications available...
Welcome to Medtech Insight
Create an account to read this article
Already a subscriber?